Related Experiment Videos

A single nucleotide polymorphism in the MDM2 gene: from a molecular and cellular explanation to clinical effect

Gareth L Bond1, Wenwei Hu, Arnold Levine

  • 1The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA.

Cancer Research
|July 5, 2005
PubMed

Insights

Researchers identified a single nucleotide polymorphism (SNP) linked to a weakened p53 pathway, accelerating tumor formation. This genetic variation impacts cancer susceptibility and disease progression in humans.

Area of Science:

  • Genetics
  • Oncology
  • Molecular Biology

Background:

  • Genetic variation influences individual differences in cancer susceptibility and disease progression.
  • The p53 stress response pathway is crucial for tumor suppression.
  • Candidate pathway approaches are used to identify genetic factors underlying complex traits.

Purpose of the Study:

  • To identify single nucleotide polymorphisms (SNPs) associated with cancer susceptibility and progression.
  • To investigate the role of the p53 pathway in cancer development.
  • To elucidate the molecular mechanisms linking genetic variation to cancer phenotypes.

Main Methods:

  • Candidate pathway approach focusing on the p53 pathway.
  • Association study to identify SNPs.
  • Molecular experiments to determine functional mechanisms.

Main Results:

  • A specific SNP was identified that associates with the p53 pathway.
  • This SNP correlates with the attenuation of the p53 pathway.
  • The identified SNP accelerates tumor formation in humans.

Conclusions:

  • Genetic variations, specifically SNPs in key pathways like p53, contribute to cancer susceptibility and progression.
  • The p53 pathway's attenuation due to specific SNPs can accelerate tumor development.
  • Molecular mechanisms underlying these phenotypes have been elucidated.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Mismatch Repair01:36

Mismatch Repair

Overview
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...